FUJIFILM Diosynth Biotechnologies broke ground in October of 2021 on a $2 billion production facility in Holly Springs, N.C. Enabling large-scale cell culture manufacturing for the creation of bulk drug substances, the structure will accommodate eight 20,000-liter bioreactors with the expansion potential for a further 24 20,000-liter bioreactors to meet market demand. Powered by clean energy, the sustainably designed complex will feature advanced systems for waste disposal and recycling. Sophisticated automation technologies will optimize the efficiency of commercial-scale fill/finish, assembly, packaging, and labelling operations. Supporting the creation of 725 positions for skilled workers by the end of 2028, the project represents the largest end-to-end cell culture CDMO facility in North America. Production at the site will begin in spring of 2025.
